Mount Sinai Medical Center & Miami Heart Institute
https://www.msmc.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mount Sinai Medical Center & Miami Heart Institute
VasoGenix Pharmaceuticals Inc.
VasoGenix Pharmaceuticals Inc. is developing a naturally occurring cardioprotectant as a front-line treatment for myocardial infarction. Its calcitonin gene related peptide drug is designed not only to restore blood flow, but also to also actively protect cardiac tissue.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice